Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
PhaseBio Announces Proposed Public Offering of Common Stock
-
PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences
-
PhaseBio to Present at Cowen and Company 40th Annual Health Care Conference
-
PhaseBio to Present at Cowen and Company 40th Annual Health Care Conference
-
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
PhaseBio Pharmaceuticals Inc. (PHAS) Prices 3.6M Shares at $12
-
PhaseBio Announces Pricing of Public Offering of Common Stock
-
PhaseBio Announces Pricing of Public Offering of Common Stock
-
PhaseBio Pharmaceuticals Inc. (PHAS) Confirms 3M Share Offering of Common Stock
-
PhaseBio Announces Proposed Public Offering of Common Stock
-
PhaseBio Announces Proposed Public Offering of Common Stock
-
PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
-
PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
-
Cowen Starts PhaseBio Pharmaceuticals Inc. (PHAS) at Outperform
-
PhaseBio Pharmaceuticals (PHAS) IPO Opens Flat
-
PhaseBio Launches Roadshow for Initial Public Offering